The Effect of Laughter Yoga in Patients with Irritable Bowel Syndrome: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study will be conducted to evaluate the effect of laughter yoga on symptom severity, depression, anxiety, stress, sleep and quality of life in patients with Irritable Bowel Syndrome (IBS). The following hypotheses will be tested in this study: H1: Laughter yoga reduces symptom severity in patients with IBS. H2: Laughter yoga reduces depression, anxiety and stress in patients with IBS. H3: Laughter yoga improves sleep quality in patients with IBS. H4: Laughter yoga improves quality of life in patients with IBS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• Diagnosed with IBS according to Rome IV criteria,

• Scoring 75 and above on the IBS-SSS score,

• DASS-42 scores of 10 and above for depression, 8 and above for anxiety, 15 and above for stress,

• Over 18 years of age,

• Bleeding hemorrhoids, all types of hernia, persistent cough, severe back pain, heart diseases, high blood pressure, urinary incontinence, major psychiatric diseases, pregnancy, cold/flu, no epilepsy, no surgery in the last three months, etc.

• Patients with a smartphone/computer where it is possible to participate in a video call for laughter yoga,

• Patients without communication problems and

• Patients who agree to participate in the study will be included in the study.

Locations
Other Locations
Turkey
Erzurum City Hospital
RECRUITING
Erzurum
Contact Information
Primary
Ebru BALA
ebrubala23@gmail.com
+905313854141
Time Frame
Start Date: 2024-12-04
Estimated Completion Date: 2025-02-28
Participants
Target number of participants: 56
Treatments
Experimental: laughter yoga group
The patients in the intervention group will have laughter yoga for 2 sessions per week (total 8 sessions) for 4 weeks in the form of meetings via zoom with the help of a smart cell phone/computer and the patients in the control group will not have laughter yoga. Patients in both groups will be evaluated for IBS-SSS at baseline and at the end of weeks 1, 2, 3 and 4. Patients in both groups will be administered DASS-42, PSQI and IBS-QOL at baseline and at the end of the 4th week. Laughter yoga is a four-part program that lasts about 40 minutes and is led by a leader. These are deep breathing exercises (5-10 minutes), clapping and warm-up exercises (10 minutes), childlike games (10 minutes) and laughter exercises (15 minutes). The philosophy of laughter yoga, a non-invasive and non-pharmacological therapy method that includes breathing techniques that combine unconditional laughter with relaxation and breathing exercises, is based on the statement movement creates emotion.
No_intervention: control group
Patients in the control group will not receive laughter yoga and will use their routine treatment. Patients in both groups will be evaluated for IBS-SSS at baseline and at the end of weeks 1, 2, 3 and 4. Patients in both groups will be administered DASS-42, PSQI and IBS-QOL at baseline and at the end of the 4th week.
Sponsors
Leads: Ataturk University

This content was sourced from clinicaltrials.gov